Literature DB >> 12419636

Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro.

H Zreiqat1, T N Crotti, C R Howlett, M Capone, B Markovic, D R Haynes.   

Abstract

Loss of bone near joint prostheses is thought to be caused by activation of recruited osteoclasts by osteolytic mediators induced by wear particles. It is proposed that particles inhibit osteogenesis during bone remodelling causing a reduction in the levels of peri-implant bone. This study explores whether prosthetic particles modulate bone formation by affecting osteoblastic bone-related mRNAs (alkaline phosphatase, pro-collagen Ialpha1, osteopontin, osteonectin, osteocalcin, bone sialoprotein and thrombospondin) or their translated proteins using titanium alloy, commercially pure titanium, and cobalt-chrome particles. The direct effect of the particles revealed no change to the expression of the bone-related mRNAs in human bone-derived cells (HBDC) at the time points investigated; although non-collagenous translated proteins expressed by these HBDC were significantly effected (p<0.05). Different patterns of expression for bone-related proteins were induced by the different particles both directly and indirectly. Inflammatory mediators (interleukin-1beta, tumor necrosis factor alpha, interleukin-6, and prostaglandin E2) had similar effects on HBDC to the media obtained from monocytes incubated with particles. This study shows that prosthetic wear particles can significantly modify the expression of bone-related proteins by osteogenic cells in vitro. These alterations in osteogenic activity at the interface of the implant and bone may be an important factor in the failure of many orthopaedic implants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12419636     DOI: 10.1016/s0142-9612(02)00324-1

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts.

Authors:  Rupak M Rajachar; Anh Q Truong; Cecilia M Giachelli
Journal:  J Mater Sci Mater Med       Date:  2008-05-16       Impact factor: 3.896

Review 2.  Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies.

Authors:  Yousef Abu-Amer; Isra Darwech; John C Clohisy
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 3.  Periprosthetic bone loss: diagnostic and therapeutic approaches.

Authors:  Loredana Cavalli; Maria Luisa Brandi
Journal:  F1000Res       Date:  2014-06-17

Review 4.  Local Cellular Responses to Titanium Dioxide from Orthopedic Implants.

Authors:  Jie J Yao; Eric A Lewallen; William H Trousdale; Wei Xu; Roman Thaler; Christopher G Salib; Nicolas Reina; Matthew P Abdel; David G Lewallen; Andre J van Wijnen
Journal:  Biores Open Access       Date:  2017-07-01

5.  Micrometer-Sized Titanium Particles Induce Aseptic Loosening in Rabbit Knee.

Authors:  Hao Xu; Cui-Cui Guo; Zheng-Yu Gao; Chang-Yao Wang; Hai-Ning Zhang; Cheng-Yu Lv; Zi-Yan Yin; Ying-Zhen Wang
Journal:  Biomed Res Int       Date:  2018-02-13       Impact factor: 3.411

6.  The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro.

Authors:  Yiyuan Zhang; Yu Lin; Lili Xiao; Eryou Feng; Wulian Wang; Liqiong Lin
Journal:  Regen Biomater       Date:  2015-08-10

7.  Aucubin suppresses Titanium particles‑mediated apoptosis of MC3T3‑E1 cells and facilitates osteogenesis by affecting the BMP2/Smads/RunX2 signaling pathway.

Authors:  Ziguan Zhu; Qingping Xie; Yazeng Huang; Shuijun Zhang; Yu Chen
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

8.  Free Radical Production, Inflammation and Apoptosis in Patients Treated With Titanium Mandibular Fixations-An Observational Study.

Authors:  Jan Borys; Mateusz Maciejczyk; Bożena Antonowicz; Jarosław Sidun; Magdalena Świderska; Anna Zalewska
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.